Navigation Links
WaferGen to Present at the Cambridge Health Institute's Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
Date:3/19/2008

ne (comprised of gene expression and genotyping analysis) had approximately $2.4 billion in worldwide revenues in 2006 ($1.74 billion for gene expression and $650 million for genotyping). Total global revenue for this market is estimated to reach approximately $5.0 billion by 2012.

WaferGen believes the SmartChip Real-Time PCR System will be the first whole genome, high throughput gene expression platform to combine the high-throughput capability and cost efficiencies of existing microarrays, with the sensitivity and accuracy of real-time PCR. Specifically, the SmartChip Real-Time PCR System's high density, rapid cycling configuration is expected to provide industry-leading throughput levels, while offering discovery and validation capabilities in a single step. The result will be the ability to conduct gene expression research at a fraction of the time and cost currently produced by existing instrument systems. For example, the company anticipates that whole genome assay time may be significantly reduced with the SmartChip Real-Time PCR System as compared to several days or months with microarrays or real-time PCR, respectively. This decrease in research time has broad economic implications across the drug development industry, particularly for pharmaceutical companies seeking avenues for reducing time to market for its therapeutics. Further, the company believes such throughput will dramatically impact the cost of such assays.

Beyond the significant time and cost advantages, the simplicity of the SmartChip Real-Time PCR System is unparalleled. The system will provide a number of key ease-of-use features including content-ready chips that can facilitate experiments without the need for advanced preparation of reagents. The user-friendly SmartChip Real-Time PCR System will accept samples out of the box, incorporating nearly all necessary substrates and chemicals. At the same time, the system will only require a very small sample size as compared to oth
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. WaferGen to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
2. WaferGen to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
3. WaferGen Announces Management Team Promotions
4. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
5. Avicena Group to Present at Noble Financial Conference
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. CEL-SCI to Present at the Noble Financial Conference
10. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
11. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ) ... of Dr. Alan Warrander to the role of ... ,, "Dr. Warrander will be responsible for the ... said Dr. Brad Thompson, President and CEO of ... of a Phase 3 trial examining REOLYSIN in ...
(Date:12/10/2009)... Microban International, Ltd., the global ... partnered with Sharp Imaging and Information Company ... to incorporate it,s third generation silver-based antimicrobial ... into the calculator keys during manufacture, Microban ... of damaging bacteria on the keys. ...
(Date:12/10/2009)... NEW YORK, Dec. 10 With the economy ... Company, Wall Street,s largest, fastest-growing small cap equity research ... of unique investment opportunities within the micro cap market ... on January 11, 2010 at the Grand Hyatt ... cap companies are overlooked and undervalued by much of ...
(Date:12/10/2009)... flow measurement, control, and level solutions, announced that ... Level Product Manager effective November 30, 2009. He ... penetration of the level measurement products around the ... Corp, a manufacturer of building materials, where he ... will report to Brooks Instrument Vice President Tim ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3
... webcast: , , What: Abbott,s exercise of its ... a subsidiary of Isis. Total acquisition price will be, ... December 17, 2008 at 8:30 a.m. ET / 5:30 a.m. PT, Where: ... Simply log onto our Web site listed, ...
... line with Jatropha World Asia 2009, scheduled 16-17 ... of interviews with top Jatropha decision makers have ... and answer session was held with Pradip Bhar, ... Magor Biofuel Limited. Offered by free download, this ...
... ... (PRWEB) December 17, 2008 -- Facilitating the entry of ... protocol analyzer, now updated to effortlessly examine not only the wireless ... modem, but also the interface between the device CPU and the ...
Other Biology Technology:Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences 2Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 2Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 3Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 4Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 2Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment 3
(Date:12/14/2009)... Pa., Dec. 14 MODA Technology Partners, ... (EM), utility and product testing for the Pharmaceutical ... 3.0, the company,s third generation mobile data acquisition ... organizations to further automate their regulated manufacturing processes. ... capabilities: ,, Fully-Configurable Test Methods: ...
(Date:12/13/2009)... may help to engineer plants that take advantage of ... finding could help to engineer crops that take advantage ... carbon dioxide they need for photosynthesis through microscopic breathing ... molecule of the gas gained, they lose hundreds of ... tighten to save water when CO 2 is ...
(Date:12/13/2009)... New Haven, Conn.A team led by Yale University ... in whole blood for the first time. Their ... online publication of Nature Nanotechnology , could ... of cancer and other diseases. , ... Professor of Engineering & Applied Science, and Tarek ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 5767 1Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego 5767 2BioMarin to Present at the Oppenheimer Healthcare Conference 5764 1BioMarin to Present at the Oppenheimer Healthcare Conference 5764 2PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 1PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 2PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 3PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 4PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 5PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 6PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 7PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 8PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 9PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results 5761 10
... new strategy developed in the Neonatal and Infant Feeding ... infants and other newborns with severe swallowing difficulties learn ... appearing in the February issue of the Journal ... Children,s were able to help 15 out of 20 ...
... N.C. Duke University Medical System researchers have discovered ... provide a new approach for future smoking-cessation products. ... Oliveira-Maia, M.D., Ph.D., a postdoctoral fellow of the Duke ... explore both the peripheral taste pathways activated by nicotine, ...
... NEW YORK The Damon Runyon Cancer Research ... researcher John Rinn, PhD, has been awarded a 2009 ... made to early-career researchers who are using "novel approaches ... member of the faculty at the Broad Institute in ...
Other Biology News:Crib-side studies help struggling newborns go home without feeding tubes 2Crib-side studies help struggling newborns go home without feeding tubes 3Nicotine activates more than just the brain's pleasure pathways 2BIDMC scientist John Rinn, Ph.D., receives Damon-Runyon Rachleff Innovation Award 2
Consists of 4 separate 100mM solutions (ATP,GTP,CTP and UTP pH 7.5) as sodium salts. 98% Pure by HPLC...
Collected from sexually mature, mixed sex, mixed breed cats. Physiochemical constituents are measured to ensure lot-to-lot consistency....
Tracker Datamatrix TRxD reads any 1D and 2D barcodes within 0.5 seconds....
Donor feline serum and plasma...
Biology Products: